Yüklüyor......

A Phase II Trial of Valproic Acid in Patients with Advanced, Radioiodine-Resistant Thyroid Cancers of Follicular Cell Origin

OBJECTIVE: Valproic acid (VA) is a histone deacetylase (HDAC) inhibitor that has antiproliferative effects on several types of cancer, including thyroid cancer. In addition, VA has been reported to upregulate the sodium-iodine symporter in thyroid cancer cells and increases radioiodine uptake in pre...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Clin Endocrinol (Oxf)
Asıl Yazarlar: Nilubol, Naris, Merkel, Roxanne, Yang, Lily, Patel, Dhaval, Reynolds, James C., Sadowski, Samira M., Neychev, Vladimir, Kebebew, Electron
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: 2016
Konular:
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC5581405/
https://ncbi.nlm.nih.gov/pubmed/27392538
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/cen.13154
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!